Severe Proteinuria Due to Idiopathic Membranous Nephropathy
1 clinical trials · Condition
◉ Watch Severe Proteinuria Due to Idiopathic Membranous Nephropathy
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria (NCT04456816) | SynAct Pharma Aps | 2020-08-31 |
Track Severe Proteinuria Due to Idiopathic Membranous Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.